Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 5, Number 1, February 2005

Book review

Review article

MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
pp. 3-8(6)
Authors: Bond, Gareth L.; Hu, Wenwei; Levine, Arnold J.

Favourites:
ADD

p53-Independent Activities of MDM2 and Their Relevance to Cancer Therapy
pp. 9-20(12)
Authors: Zhang, Zhuo; Zhang, Ruiwen

Favourites:
ADD

MDM2 Splice Variants and Their Therapeutic Implications
pp. 21-26(6)
Author: Harris, L. C.

Favourites:
ADD

MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy
pp. 27-41(15)
Authors: Rayburn, Elizabeth; Zhang, Ruiwen; He, Jie; Wang, Hui

Favourites:
ADD

Chemosensitization by Antisense Oligonucleotides Targeting MDM2
pp. 51-56(6)
Authors: Bianco, Roberto; Ciardiello, Fortunato; Tortora, Giampaolo

Favourites:
ADD

Small Molecule Antagonists of the MDM2 Oncoprotein as Anticancer Agents
pp. 57-68(12)
Authors: Buolamwini, John K.; Addo, James; Kamath, Shantaram; Patil, Shivaputra; Mason, Mason; Ores, Marian

Favourites:
ADD

Addendum

Author Index to Volume 4
pp. 69-71(3)
Author: Bentham Science Publishers

Favourites:
ADD

Subject Index to Volume 4
pp. 73-84(12)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more